BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30127060)

  • 1. Activated CARD11 accelerates germinal center kinetics, promoting mTORC1 and terminal differentiation.
    Wray-Dutra MN; Chawla R; Thomas KR; Seymour BJ; Arkatkar T; Sommer KM; Khim S; Trapnell C; James RG; Rawlings DJ
    J Exp Med; 2018 Sep; 215(9):2445-2461. PubMed ID: 30127060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B Cell-Intrinsic mTORC1 Promotes Germinal Center-Defining Transcription Factor Gene Expression, Somatic Hypermutation, and Memory B Cell Generation in Humoral Immunity.
    Raybuck AL; Cho SH; Li J; Rogers MC; Lee K; Williams CL; Shlomchik M; Thomas JW; Chen J; Williams JV; Boothby MR
    J Immunol; 2018 Apr; 200(8):2627-2639. PubMed ID: 29531165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M17, a gene specific for germinal center (GC) B cells and a prognostic marker for GC B-cell lymphomas, is dispensable for the GC reaction in mice.
    Schenten D; Egert A; Pasparakis M; Rajewsky K
    Blood; 2006 Jun; 107(12):4849-56. PubMed ID: 16493007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.
    Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S
    Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas.
    Reimann M; Schrezenmeier J; Richter-Pechanska P; Dolnik A; Hick TP; Schleich K; Cai X; Fan DNY; Lohneis P; Maßwig S; Denker S; Busse A; Knittel G; Flümann R; Childs D; Childs L; Gätjens-Sanchez AM; Bullinger L; Rosenwald A; Reinhardt HC; Schmitt CA
    Blood; 2021 May; 137(20):2785-2799. PubMed ID: 33232972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth.
    Hashwah H; Schmid CA; Kasser S; Bertram K; Stelling A; Manz MG; Müller A
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9701-9706. PubMed ID: 28831000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen Complexed with a TLR9 Agonist Bolsters c-Myc and mTORC1 Activity in Germinal Center B Lymphocytes.
    Wigton EJ; DeFranco AL; Ansel KM
    Immunohorizons; 2019 Aug; 3(8):389-401. PubMed ID: 31427364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative Control of Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling by an Unusual Array of Redundant Repressive Elements.
    Jattani RP; Tritapoe JM; Pomerantz JL
    J Biol Chem; 2016 Apr; 291(16):8324-36. PubMed ID: 26884335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation.
    Rivas MA; Meydan C; Chin CR; Challman MF; Kim D; Bhinder B; Kloetgen A; Viny AD; Teater MR; McNally DR; Doane AS; Béguelin W; Fernández MTC; Shen H; Wang X; Levine RL; Chen Z; Tsirigos A; Elemento O; Mason CE; Melnick AM
    Nat Immunol; 2021 Feb; 22(2):240-253. PubMed ID: 33432228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma.
    Bartolomé-Izquierdo N; de Yébenes VG; Álvarez-Prado AF; Mur SM; Lopez Del Olmo JA; Roa S; Vazquez J; Ramiro AR
    Blood; 2017 Apr; 129(17):2408-2419. PubMed ID: 28188132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the transcription factor FOXO1 mimic positive selection signals to promote germinal center B cell expansion and lymphomagenesis.
    Roberto MP; Varano G; Vinas-Castells R; Holmes AB; Kumar R; Pasqualucci L; Farinha P; Scott DW; Dominguez-Sola D
    Immunity; 2021 Aug; 54(8):1807-1824.e14. PubMed ID: 34380064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exit from germinal center to become quiescent memory B cells depends on metabolic reprograming and provision of a survival signal.
    Inoue T; Shinnakasu R; Kawai C; Ise W; Kawakami E; Sax N; Oki T; Kitamura T; Yamashita K; Fukuyama H; Kurosaki T
    J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33045065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-γ receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity.
    Domeier PP; Chodisetti SB; Soni C; Schell SL; Elias MJ; Wong EB; Cooper TK; Kitamura D; Rahman ZS
    J Exp Med; 2016 May; 213(5):715-32. PubMed ID: 27069112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rewired NFκB signaling as a potentially actionable feature of activated B-cell-like diffuse large B-cell lymphoma.
    Knittel G; Liedgens P; Korovkina D; Pallasch CP; Reinhardt HC
    Eur J Haematol; 2016 Dec; 97(6):499-510. PubMed ID: 27526684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germinal center B cell maintenance and differentiation are controlled by distinct NF-κB transcription factor subunits.
    Heise N; De Silva NS; Silva K; Carette A; Simonetti G; Pasparakis M; Klein U
    J Exp Med; 2014 Sep; 211(10):2103-18. PubMed ID: 25180063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic CARD11 mutations affect B cell development and differentiation through a noncanonical pathway.
    Wei Z; Zhang Y; Chen J; Hu Y; Jia P; Wang X; Zhao Q; Deng Y; Li N; Zang Y; Qin J; Wang X; Lu W
    Sci Immunol; 2019 Nov; 4(41):. PubMed ID: 31784498
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Masle-Farquhar E; Jeelall Y; White J; Bier J; Deenick EK; Brink R; Horikawa K; Goodnow CC
    Front Immunol; 2023; 14():1095257. PubMed ID: 36960072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAD4 plays a critical role in germinal center response by regulating Bcl-6 and NF-κB activation.
    Gao F; Yang Y; Wang Z; Gao X; Zheng B
    Cell Immunol; 2015 Mar; 294(1):1-8. PubMed ID: 25656449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
    Brown PJ; Wong KK; Felce SL; Lyne L; Spearman H; Soilleux EJ; Pedersen LM; Møller MB; Green TM; Gascoyne DM; Banham AH
    Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of mTORC1 Signaling in Osterix-Expressing Cells Impairs B-cell Differentiation.
    Wang Y; Xiao M; Tao C; Chen J; Wang Z; Yang J; Chen Z; Zou Z; Liu A; Cai D; Jiang Y; Ding C; Li M; Bai X
    J Bone Miner Res; 2018 Apr; 33(4):732-742. PubMed ID: 29206332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.